← All trials
NCT05390307
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 22, 2022
- Primary completion
- Jul 1, 2023
- Completion date
- Jul 1, 2024
- First posted
- May 25, 2022
- Last posted
- May 25, 2022
- Enrollment
- 72
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dasman Diabetes InstituteLead sponsor
- Dasman Diabetes InstituteReponsible party - principal investigator
- Dasman Diabetes InstituteSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.